Type One Diabetes Completed Phase Trials for Insulin human (DB00030)

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

IndicationStatusPhase
DBCOND0076728 (Type One Diabetes)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03179280
Effect of Dual-wave Insulin Bolus on Postprandial GlycaemiaTreatment
NCT02824510
Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesTreatment
NCT02248454
Insulin Bolus Required for High Fat Foods in Type 1 DiabetesTreatment
NCT02359617
Continuous Glucose Sensing at the Site of Subcutaneous Insulin AdministrationBasic Science
NCT00741429
A 2-Month Safety Follow-Up Trial
NCT01424046
Health Care for Type 1 Diabetes in Developing WorldTreatment
NCT00522210
Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 DiabetesTreatment
NCT00626080
Insulin Detemir Action in Cerebro
NCT04233203
Faster Aspart on Insulin-pump Treated T1DM Patients
NCT04149262
Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor
NCT04876079
Prevention of Mild-to-moderate Hypoglycemia in Type 1 DiabetesTreatment
NCT04267770
Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin InfusionSupportive Care
NCT02632032
Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon
NCT00927524
Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult ControlsTreatment
NCT02077348
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.Basic Science
NCT01919788
Intracellular Counter-regulatory Mechanisms Following Low Blood GlucoseBasic Science
NCT04420728
Closed-Loop Insulin in Mothers With Type 1 Diabetes and Baby Feeding PracticesTreatment
NCT06422494
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-IIBasic Science
NCT01492218
Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
NCT01492959
Observational Study With InnoLet® in Daily Clinical Practice
NCT01493388
To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1
NCT01492205
NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
NCT06055829
The Adjustment of Doses in Diabetes Mellitus Type I
NCT00410033
Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinTreatment
NCT01483651
Physiologic Response to Glucagon at Varying Insulin LevelsBasic Science
NCT01492153
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
NCT03556098
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 DiabetesBasic Science
NCT00858897
Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study ABasic Science
NCT03793283
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice
NCT02772783
Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes MellitusTreatment
NCT01628341
French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients
NCT02204839
Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DMBasic Science
NCT02117622
A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India
NCT00858273
Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study BBasic Science
NCT01542489
Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
NCT01874392
Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind CorpTreatment